Skip to main content
Clinical Trials/NCT03492307
NCT03492307CompletedNot Applicable

Weight-based Flow Rates for Children With Bronchiolitis on High-Flow Nasal Cannula: A Pilot Randomized Control Trial

Boston Children's Hospital1 site in 1 country60 target enrollmentStarted: May 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Treatment failure

Study Overview

Brief Summary

This is a pilot study comparing a weight-based high-flow nasal cannula (HFNC) protocol with the current standard HFNC protocol for children <2yo admitted to South Shore Hospital with bronchiolitis. We currently use a flat limit of 8 liters of HFNC to support work of breathing and hypoxia in these patients. We will compare that to a weight-based protocol, which will provide 2L/kg/min of flow (flows generally between 6 and 20L/minute) to this patient population. The goal of this pilot study is to assess the feasibility of our study design. We will evaluate the functionality of a new weight-based flow protocol. We will also evaluate the functionality of a new bronchiolitis scoring tool, the Bronchiolitis Assessment Severity Score (BASS), and it's ability to guide care through the new protocol. We are also testing the feasibility of recruitment, randomization and retention. We are ultimately interested in whether a weight-based flow protocol reduces need for escalation to ICU-level care for children with moderate-severe bronchiolitis on HFNC.

Detailed Description

This is a pilot study comparing a weight-based high-flow nasal cannula (HFNC) protocol with the current standard HFNC protocol for children <2yo admitted to South Shore Hospital with bronchiolitis. We currently use a flat limit of 8 liters of HFNC to support work of breathing and hypoxia in these patients. We will compare that to a weight-based protocol, which will provide 2L/kg/min of flow (flows generally between 6 and 20L/minute) to this patient population. The goal of this pilot study is to assess the feasibility of our study design. We will evaluate the functionality of a new weight-based flow protocol. We will also evaluate the functionality of a new bronchiolitis scoring tool, the Bronchiolitis Assessment Severity Score (BASS), and it's ability to guide care through the new protocol. We are also testing the feasibility of recruitment, randomization and retention. We are ultimately interested in whether a weight-based flow protocol reduces need for escalation to ICU-level care for children with moderate-severe bronchiolitis on HFNC.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
— to 2 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •admission to inpatient pediatrics
  • •clinical diagnosis of bronchiolitis
  • •BASS score of moderate or severe

Exclusion Criteria

  • •non-english speakers
  • •patients with urgent need for CPAP, BIPAP or intubation

Arms & Interventions

Standard Flow Protocol

Active Comparator

Patients randomized to this arm will receive HFNC according to our current protocol with a maximum of 8L/min.

Intervention: Standard Flow for HFNC (Maximum 8L/minute) (Other)

Weight-Based Flow Protocol

Experimental

Patients randomized to this arm will receive HFNC according to a weight-based algorithm at 2L/kg/min.

Intervention: Weight-Based Flow for High Flow Nasal Cannula (HFNC) (2L/kg/minute) (Other)

Outcomes

Primary Outcomes

Treatment failure

Time Frame: During hospital admission

Need for escalation to NIV (CPAP or BIPAP) or intubation

Length of Stay

Time Frame: During hospital admission

Length of hospital stay (admission to discharge or transfer)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Alla Smith

Principal Investigator

Boston Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials

Weight-based Flow Rates for Children With... | Clinical Trial